Loading clinical trials...
Loading clinical trials...
The purpose of this study is to measure the effect of omeprazole on intestinal calcium absorption in postmenopausal women.
Existing literature makes it unclear whether proton pump inhibitor therapy truly decreases intestinal calcium absorption. Up to 25 postmenopausal women will participate in this study. The primary study outcome is the change in intestinal calcium absorption following omeprazole therapy 40 mg daily for 30 days. The secondary outcomes include the change in urine n-telopeptide. We will interview women and review their medical records to determine eligibility. Eligible subjects will undergo three calcium absorption studies. The first 2 studies will determine the monthly variation in calcium absorption, while the 3rd study will occur after taking 40 mg of omeprazole daily for 30 days. Women will present to the research unit in the early morning and receive an oral and intravenous calcium tracer with breakfast. Over the next 24 hours, we will collect all urine for measurement of its calcium content. During the first stay, we will measure each subject's gastric pH by collecting gastric fluid from a temporary nasogastric tube. In consenting subjects we will collect one tube of blood, isolate its DNA.
Age
All ages
Sex
FEMALE
Healthy Volunteers
Yes
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Start Date
January 1, 2008
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2010
Last Updated
February 15, 2013
23
ACTUAL participants
Omeprazole
DRUG
Lead Sponsor
University of Wisconsin, Madison
NCT07310927
NCT06953986
NCT06731608
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions